Regeneron Granted Marketing Authorization For Libtayo In Japan For Recurrent Cervical Cancer

BRUSSELS/FRANKFURT/PARIS (dpa-AFX) - Regeneron Pharmaceuticals (REGN) announced the Ministry of Health, Labor and Welfare in Japan has granted marketing and manufacturing authorization for Libtayo

Related Keywords

Japan ,Brussels ,Bruxelles Capitale ,Belgium , ,Regeneron Pharmaceuticals ,European Commission ,Ministry Of Health ,More Such Health News ,Regeneron ,Granted ,Marketing ,Authorization ,Libtayo ,Recurrent ,Cervical ,Dancer ,